MAIN STAGE | New Trends in China's Pharmaceutical R&D
SESSION 1:
Global Market & Ecosystem
SESSION 2:
Regulatory Pathways and Regional Harmonization
SESSION 3:
Digital Transformation: Pharma 4.0
DAY1 STAGE C | Partnering, Business Development & Licensing
SESSION 1:
Cross-Border Investment and Strategic Partnerships
SESSION 2:
Capital Markets and Dealmakers Showcase
SESSION 3:
Biotech Showcase
DAY1 STAGE D | AI and Data in Pharma R&D
SESSION 1:
AI and Machine Learning in Drug Discovery
SESSION 2:
Data Science in Drug Design and Optimization
SESSION 3:
Integration of AI in Drug Development Workflow
SESSION 4:
Real-World Data (RWD) and Evidence (RWE)
DAY2 STAGE A | Drug Discovery & Development
SESSION 1:
New Frontiers in Drug Discovery
SESSION 2:
Emerging Therapeutic Modalities and Platforms
SESSION 3:
Breakthroughs in Oncology Drug Discovery
SESSION 4:
Translational Breakthroughs in Drug Discovery
DAY2 STAGE B | Clinical Trials
SESSION 1:
Innovative Trial Designs to Enhance Efficiency
SESSION 2:
Patient Recruitment and Engagement
SESSION 3:
Digital Transformation in Clinical Trials
SESSION 4:
Patient-Centric Innovations in Clinical Trials
DAY2 STAGE C | Cell & Gene Therapy R&D
SESSION 1:
Advancing Next-Generation Cell Therapy
SESSION 2:
Breakthroughs in Gene Editing and Delivery Systems
SESSION 3:
Emerging Trends in Cell & Gene Therapy Applications
SESSION 4:
CMC and Quality in Cell & Gene Therapy Development
DAY2 AM STAGE D | ADC R&D
SESSION 1:
Advancing the Science of ADCs
SESSION 2:
Differentiated Development of ADC Drugs
DAY2 PM STAGE D | Nucleic Acid Therapeutics
SESSION 1:
Innovations in Nucleic Acid Therapeutics
SESSION 2:
Delivery Innovations and Emerging Technologies
DAY2 STAGE D | Nucleic Acid and mRNA Drug
SESSION 1:
Breakthroughs in Nucleic Acid Therapies
SESSION 2:
Delivery Technologies and Innovations for Nucleic Acid Drugs
SESSION 3:
mRNA Vaccine and Drug Development Progress and Future Applications mRNA
DAY 2 AM STAGE E | Immuno-Oncology Drug
SESSION 1:
Advances in Cancer Immunotherapy
SESSION 2:
Personalized Cancer Immunotherapy and Novel Targets
DAY2 STAGE F | Cell and Gene Therapy
SESSION 1:
Breakthroughs in Cell Therapy
SESSION 2:
Gene Editing and Therapy Innovations
SESSION 3:
Emerging Therapies in CGT
SESSION 4:
CGT Drug CMC Process Development CGT
DAY 2 AM STAGE G | Peptide Drug
SESSION 1:
Innovations in Peptide Synthesis and Design
SESSION 2:
Peptide-Based Innovative Drugs and Immuno-Oncology
DAY2 PM STAGE G | Radiopharmaceutical
SESSION 1:
Advancements in Radiopharmaceutical Technology
SESSION 2:
Regulatory and Clinical Challenges in Radiopharmaceuticals
